Tenaya Therapeutics(TNYA)
Focus: Tenaya Therapeutics is a public-stage cardiovascular biotech focused on gene therapy and novel therapeutics for rare cardiomyopathies and metabolic diseases. The company operates as a lean, clinical-stage organization with early-phase pipeline assets targeting unmet needs in genetic heart disease.
Profile data last refreshed 16h ago · AI intelligence enriched 21h ago
Funding Stage
PUBLIC
Open Jobs
0
About Tenaya Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Tenaya Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated
Arrhythmogenic Right Ventricular CardiomyopathyNatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
CardiomyopathyClinical Trials (1)
Help build intelligence for Tenaya Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.